CEO & President
Vermilion Therapeutics Inc.
The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$2.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.